537 related articles for article (PubMed ID: 14609342)
1. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin reductase from Plasmodium falciparum: evidence for interaction between the C-terminal cysteine residues and the active site disulfide-dithiol.
Wang PF; Arscott LD; Gilberger TW; Müller S; Williams CH
Biochemistry; 1999 Mar; 38(10):3187-96. PubMed ID: 10074374
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents.
Andricopulo AD; Akoachere MB; Krogh R; Nickel C; McLeish MJ; Kenyon GL; Arscott LD; Williams CH; Davioud-Charvet E; Becker K
Bioorg Med Chem Lett; 2006 Apr; 16(8):2283-92. PubMed ID: 16458512
[TBL] [Abstract][Full Text] [Related]
4. Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: a divinyl ketone as key intermediate.
Lee B; Bauer H; Melchers J; Ruppert T; Rattray L; Yardley V; Davioud-Charvet E; Krauth-Siegel RL
J Med Chem; 2005 Nov; 48(23):7400-10. PubMed ID: 16279799
[TBL] [Abstract][Full Text] [Related]
5. The relationship of the redox potentials of thioredoxin and thioredoxin reductase from Drosophila melanogaster to the enzymatic mechanism: reduced thioredoxin is the reductant of glutathione in Drosophila.
Cheng Z; Arscott LD; Ballou DP; Williams CH
Biochemistry; 2007 Jul; 46(26):7875-85. PubMed ID: 17550271
[TBL] [Abstract][Full Text] [Related]
6. Function of Glu-469' in the acid-base catalysis of thioredoxin reductase from Drosophila melanogaster.
Huang HH; Arscott LD; Ballou DP; Williams CH
Biochemistry; 2008 Dec; 47(48):12769-76. PubMed ID: 18991392
[TBL] [Abstract][Full Text] [Related]
7. Acid-base catalysis in the mechanism of thioredoxin reductase from Drosophila melanogaster.
Huang HH; Arscott LD; Ballou DP; Williams CH
Biochemistry; 2008 Feb; 47(6):1721-31. PubMed ID: 18211101
[TBL] [Abstract][Full Text] [Related]
8. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin reductase-thioredoxin fusion enzyme from Mycobacterium leprae: comparison with the separately expressed thioredoxin reductase.
Wang PF; Marcinkeviciene J; Williams CH; Blanchard JS
Biochemistry; 1998 Nov; 37(46):16378-89. PubMed ID: 9819230
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
[TBL] [Abstract][Full Text] [Related]
11. A mechanistic investigation of the C-terminal redox motif of thioredoxin reductase from Plasmodium falciparum.
Snider GW; Dustin CM; Ruggles EL; Hondal RJ
Biochemistry; 2014 Jan; 53(3):601-9. PubMed ID: 24400600
[TBL] [Abstract][Full Text] [Related]
12. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant.
Zhao R; Masayasu H; Holmgren A
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8579-84. PubMed ID: 12070343
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of high Mr thioredoxin reductase from Drosophila melanogaster.
Bauer H; Massey V; Arscott LD; Schirmer RH; Ballou DP; Williams CH
J Biol Chem; 2003 Aug; 278(35):33020-8. PubMed ID: 12816954
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex.
Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K
J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
16. The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis.
Fritz-Wolf K; Urig S; Becker K
J Mol Biol; 2007 Jun; 370(1):116-27. PubMed ID: 17512005
[TBL] [Abstract][Full Text] [Related]
17. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
Biot C; Dessolin J; Grellier P; Davioud-Charvet E
Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
[TBL] [Abstract][Full Text] [Related]
19. Ebselen: a thioredoxin reductase-dependent catalyst for alpha-tocopherol quinone reduction.
Fang J; Zhong L; Zhao R; Holmgren A
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):103-9. PubMed ID: 15979675
[TBL] [Abstract][Full Text] [Related]
20. A new mechanism of action for the anticancer drug mitomycin C: mechanism-based inhibition of thioredoxin reductase.
Paz MM; Zhang X; Lu J; Holmgren A
Chem Res Toxicol; 2012 Jul; 25(7):1502-11. PubMed ID: 22694104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
